DeepMed Research

Abramson Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pennmedicine.org

Clinical Trials

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Completed

Conditions: Stage III Renal Cell Cancer
Renal Cell Carcinoma
Stage IV Renal Cell Cancer

Interventions: Genetic: mutation analysis
Other: pharmacological study
Procedure: dynamic contrast-enhanced magnetic resonance imaging
Drug: sunitinib malate
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis

First Posted Date: 2009-12-04

Last Posted Date: 2019-06-25

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 43

Registration Number: NCT01026337

Locations: 🇺🇸
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas

Phase 1

Completed

Conditions: Adult Brain Stem Glioma
Adult Oligodendroglioma
Adult Pineal Gland Astrocytoma
Adult Grade II Meningioma
Adult Diffuse Astrocytoma
Adult Pineocytoma
Adult Brain Tumor
Adult Ependymoma
Adult Melanocytic Lesion
Adult Meningeal Hemangiopericytoma

Interventions: Radiation: proton beam radiation therapy
Procedure: quality-of-life assessment
Other: questionnaire administration

First Posted Date: 2009-12-03

Last Posted Date: 2020-12-10

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 23

Registration Number: NCT01024907

Locations: 🇺🇸
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

Phase 2

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Procedure: Quality-of-life assessment
Procedure: Sleep disorder therapy
Other: Questionnaire Administration
Procedure: Cognitive Assessment
Drug: Armodafinil
Other: Placebo
Procedure: Quality of Life Assessment
Procedure: Fatigue assessment and management
Procedure: Management of Therapy
Procedure: Fatifue assessment and management
Procedure: Management of therapy and complications

First Posted Date: 2009-11-24

Last Posted Date: 2020-04-09

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 226

Registration Number: NCT01019187

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer

Not Applicable

Terminated

Conditions: Breast Cancer
Lymphedema

Interventions: Other: questionnaire administration
Other: lymphedema management

First Posted Date: 2009-11-24

Last Posted Date: 2015-03-25

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 60

Registration Number: NCT01019512

Locations: 🇺🇸
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Phase 2

Withdrawn

Conditions: Stage IIA Cervical Cancer
Stage III Cervical Cancer
Stage IVA Cervical Cancer
Cervical Cancer
Stage IB Cervical Cancer
Stage IIB Cervical Cancer

Interventions: Radiation: proton beam radiation therapy
Radiation: radiation therapy treatment planning/simulation
Drug: cisplatin

First Posted Date: 2009-11-24

Last Posted Date: 2020-04-03

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Registration Number: NCT01019278

Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx

Not Applicable

Completed

Conditions: Squamous Cell Carcinoma

Interventions: Drug: fluorine F18 EF5
Procedure: immunohistochemistry staining method
Procedure: biopsy
Procedure: Positron Emission tomography

First Posted Date: 2009-11-24

Last Posted Date: 2020-04-28

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 5

Registration Number: NCT01020097

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Other: Survey Administration

First Posted Date: 2009-11-24

Last Posted Date: 2020-04-09

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 2

Registration Number: NCT01018901

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

Phase 1

Completed

Conditions: Glioma

Interventions: Drug: Nelfinavir

First Posted Date: 2009-11-24

Last Posted Date: 2019-04-12

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 31

Registration Number: NCT01020292

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma

Not Applicable

Completed

Conditions: Brain Tumor

Interventions: Procedure: Magnetic Resonance Imaging
Procedure: Diffusion Tensor Imaging
Procedure: Magnetic Resonance Spectroscopic Imaging
Procedure: Dynamic Contract-Enhanced magnetic resonance imaging
Procedure: Diffusion-weighted magnetic resonance imaging

First Posted Date: 2009-11-23

Last Posted Date: 2012-12-11

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 10

Registration Number: NCT01018329

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Procedure: Single Photon Emission Computed Tomography
Procedure: Acupuncture Therapy
Other: Questionnaire Administration
Other: Laboratory Biomarker Analysis

First Posted Date: 2009-11-23

Last Posted Date: 2016-01-26

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 7

Registration Number: NCT01018108

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy